• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI 检测到轻度认知障碍和早期阿尔茨海默病的脑微出血:与 PET 成像中的 tau 和淀粉样 β 的关联。

Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging.

机构信息

From the Department of Radiology (B.S.R.) and Division of Mental Health of Older Adults, Department of Psychiatry and Psychotherapy (B.S.R., S.M., R.P.), University Hospital, Ludwig-Maximilians-Universität München, Nussbaumstr 7, 80336 Munich, Germany; Department of Psychiatry, University of British Columbia, Vancouver, Canada (F.G.); German Center for Neurodegenerative Diseases Munich, Germany (R.P.); Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (R.P.); and Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, England (R.P.).

出版信息

Radiology. 2020 Jul;296(1):134-142. doi: 10.1148/radiol.2020191904. Epub 2020 May 5.

DOI:10.1148/radiol.2020191904
PMID:32368960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7325705/
Abstract

Background Growing evidence indicates an association between cerebral microhemorrhages (MHs) and amyloid β accumulation in Alzheimer disease (AD), but to the knowledge of the authors the association with tau burden is unknown. Purpose To investigate the association between cerebral MH load and tau pathologic structure measured in healthy older individuals and individuals along the AD spectrum, stratified by using the A (amyloid β)/T (tau)/N (neurodegeneration) biomarker classification system. Materials and methods In this prospective cohort study, participants from the AD Neuroimaging Initiative were included (healthy control participants, participants with mild cognitive impairment, and participants with AD dementia; data from October 2005 to January 2019). T2*-weighted gradient-echo MRI was performed to quantify MH, fluorine 18 (F) flortaucipir (AV-1451) PET was performed to quantify tau, and F-florbetaben/F- florbetapir (AV45) PET was performed to quantify amyloid β to study associations of MH with regional and global tau and amyloid β load. Associations with cerebrospinal fluid (CSF) biomarkers (amyloid β1-42, total tau, phosphorylated tau 181) were also assessed. Analysis of covariance and Spearman rank correlation test for cross-sectional analysis and Wilcoxon signed rank test for longitudinal analyses were used, controlling for multiple comparisons (Bonferroni significance threshold, < .008). Results Evaluated were 343 participants (mean age, 75 years ± 7; 186 women), including 205 participants who were A-TN- (mean age, 73 years ± 7; 115 women), 80 participants who were A+TN- (mean age, 76 years ± 7; 38 women), and 58 participants who were A+TN+ (mean age, 77 ± 8; 34 women). MH count was associated with global (Spearman ρ = 0.27; = .004) and frontal (ρ = 0.27; = .005) amyloid β load and global tau load (ρ = 0.31; = .001). In a longitudinal analysis, MH count increased significantly over approximately 5 years in the entire cohort (T-1, 81 [range, 0-6 participants]; T0, 214 [range, 0-58 participants]; < .001), in A+TN+ (T-1, 20 [range, 0-5 participants]; T0, 119 [range, 1-58 participants]; < .001), A+TN- (T-1, 31 [range, 0-6 participants]; T0, 43 [range, 0-8 participants]; = .03), and A-TN- (T-1, 30 [range, 0-4 participants]; T0, 52 [range, 0-6 participants]; = .007). A higher MH count was associated with higher future global (ρ = 0.29; = .008) and parietal (ρ = 0.31; = .005) amyloid β and parietal tau load (ρ = 0.31; = .005). Conclusion Cerebral microhemorrhage load is associated spatially with tau accumulation, both cross-sectionally and longitudinally. © RSNA, 2020

摘要

背景 越来越多的证据表明脑微出血 (MHs) 与阿尔茨海默病 (AD) 中的淀粉样 β 积聚之间存在关联,但作者认为其与 tau 负担的关联尚不清楚。目的 研究在健康老年人和 AD 谱个体中,脑 MH 负荷与 tau 病理结构之间的关系,使用 A (淀粉样 β)/T (tau)/N (神经退行性变) 生物标志物分类系统进行分层。材料与方法 本前瞻性队列研究纳入了 AD 神经影像学倡议的参与者(健康对照参与者、轻度认知障碍参与者和 AD 痴呆症参与者;数据采集时间为 2005 年 10 月至 2019 年 1 月)。采用 T2*-加权梯度回波 MRI 定量 MH,氟 18 (F) 氟替卡培 (AV-1451) PET 定量 tau,F-氟比他滨/F-氟比卡培 (AV45) PET 定量淀粉样 β,以研究 MH 与区域和全局 tau 以及淀粉样 β 负荷的相关性。还评估了与脑脊液 (CSF) 生物标志物(淀粉样 β1-42、总 tau、磷酸化 tau 181)的相关性。使用协方差分析和 Spearman 秩相关检验进行横断面分析,Wilcoxon 符号秩检验进行纵向分析,同时控制了多重比较(Bonferroni 显著性阈值,<.008)。结果 共评估了 343 名参与者(平均年龄 75 岁±7;186 名女性),其中 205 名参与者为 A-TN-(平均年龄 73 岁±7;115 名女性),80 名参与者为 A+TN-(平均年龄 76 岁±7;38 名女性),58 名参与者为 A+TN+(平均年龄 77±8;34 名女性)。MH 计数与全局(Spearman ρ = 0.27; =.004)和额部(ρ = 0.27; =.005)淀粉样 β 负荷以及全局 tau 负荷呈正相关(ρ = 0.31; =.001)。在一项纵向分析中,整个队列的 MH 计数在大约 5 年内显著增加(T-1,81[范围,0-6 名参与者];T0,214[范围,0-58 名参与者];<.001),在 A+TN+(T-1,20[范围,0-5 名参与者];T0,119[范围,1-58 名参与者];<.001)、A+TN-(T-1,31[范围,0-6 名参与者];T0,43[范围,0-8 名参与者];=.03)和 A-TN-(T-1,30[范围,0-4 名参与者];T0,52[范围,0-6 名参与者];=.007)。更高的 MH 计数与未来的全局(ρ = 0.29; =.008)和顶叶(ρ = 0.31; =.005)淀粉样 β 以及顶叶 tau 负荷呈正相关(ρ = 0.31; =.005)。结论 脑微出血负荷与 tau 积聚存在空间相关性,无论是在横断面还是纵向研究中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb6/7325705/c6bbec1cd266/radiol.2020191904.VA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb6/7325705/c6bbec1cd266/radiol.2020191904.VA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb6/7325705/c6bbec1cd266/radiol.2020191904.VA.jpg

相似文献

1
Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging.MRI 检测到轻度认知障碍和早期阿尔茨海默病的脑微出血:与 PET 成像中的 tau 和淀粉样 β 的关联。
Radiology. 2020 Jul;296(1):134-142. doi: 10.1148/radiol.2020191904. Epub 2020 May 5.
2
Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.载脂蛋白 E ε4 与内侧颞叶 tau 相关,与淀粉样蛋白-β无关。
JAMA Neurol. 2020 Apr 1;77(4):470-479. doi: 10.1001/jamaneurol.2019.4421.
3
Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.内侧颞叶和皮质淀粉样蛋白与阿尔茨海默病患者的日常功能损害有关。
Alzheimers Res Ther. 2019 Jan 31;11(1):14. doi: 10.1186/s13195-019-0471-6.
4
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.Tau 正电子发射断层扫描作为临床前和前驱期阿尔茨海默病预后标志物的准确性:与淀粉样蛋白正电子发射断层扫描和磁共振成像的头对头比较。
JAMA Neurol. 2021 Aug 1;78(8):961-971. doi: 10.1001/jamaneurol.2021.1858.
5
Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.常染色体显性遗传阿尔茨海默病患者中淀粉样蛋白和tau 蛋白蓄积的相关性。
JAMA Neurol. 2018 May 1;75(5):548-556. doi: 10.1001/jamaneurol.2017.4907.
6
Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.主观认知衰退与tau蛋白病的区域特异性关联,独立于整体β-淀粉样蛋白负荷。
JAMA Neurol. 2017 Dec 1;74(12):1455-1463. doi: 10.1001/jamaneurol.2017.2216.
7
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.在女性和淀粉样蛋白阳性的年轻受试者中,tau 聚集物的积累速度更高。
Brain. 2020 Dec 1;143(12):3805-3815. doi: 10.1093/brain/awaa327.
8
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.阿尔茨海默病患者 Tau、Aβ 与皮质厚度和认知的相关性。
Neurology. 2019 Feb 5;92(6):e601-e612. doi: 10.1212/WNL.0000000000006875. Epub 2019 Jan 9.
9
18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.18F-Flortaucipir PET 与阿尔茨海默病导致的轻度认知障碍患者的脑脊液、认知和神经影像学的相关性。
J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330.
10
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography.磷酸化 tau 生物标志物与淀粉样 PET 与 tau PET 的关联。
JAMA Neurol. 2023 Feb 1;80(2):188-199. doi: 10.1001/jamaneurol.2022.4485.

引用本文的文献

1
Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co-Pathology in Lewy Body Disease.血浆磷酸化Tau181作为路易体病中阿尔茨海默病共病病理的生物标志物。
Mov Disord. 2025 May 29. doi: 10.1002/mds.30238.
2
Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening.衰老、线粒体功能障碍与脑微出血:SS-31(依拉米肽)的临床前评估及用于脑微血管保护治疗筛选的高通量机器学习驱动成像流程的开发
Geroscience. 2025 Apr 2. doi: 10.1007/s11357-025-01634-5.
3

本文引用的文献

1
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.血脑屏障破坏是人类认知功能障碍的早期生物标志物。
Nat Med. 2019 Feb;25(2):270-276. doi: 10.1038/s41591-018-0297-y. Epub 2019 Jan 14.
2
Predicting diagnosis and cognition with F-AV-1451 tau PET and structural MRI in Alzheimer's disease.使用 F-AV-1451 tau PET 和结构 MRI 预测阿尔茨海默病的诊断和认知。
Alzheimers Dement. 2019 Apr;15(4):570-580. doi: 10.1016/j.jalz.2018.12.001. Epub 2019 Jan 25.
3
Vascular Risk and β-Amyloid Are Synergistically Associated with Cortical Tau.
Cerebral Microhemorrhages in Children With Congenital Heart Disease: Prevalence, Risk Factors, and Association With Neurodevelopmental Outcomes.
先天性心脏病患儿的脑微出血:患病率、危险因素及其与神经发育结局的关联
J Am Heart Assoc. 2025 Feb 4;14(3):e035359. doi: 10.1161/JAHA.123.035359. Epub 2025 Feb 3.
4
A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles.一篇关于用于tau神经原纤维缠结正电子发射断层扫描成像的氟替卡匹文献综述。
Brain Commun. 2023 Nov 16;6(1):fcad305. doi: 10.1093/braincomms/fcad305. eCollection 2024.
5
Prediction of Amyloid β-Positivity with both MRI Parameters and Cognitive Function Using Machine Learning.利用机器学习通过MRI参数和认知功能预测β淀粉样蛋白阳性
J Korean Soc Radiol. 2023 May;84(3):638-652. doi: 10.3348/jksr.2022.0084. Epub 2023 May 18.
6
[Association between Cerebral Small Vessel and Alzheimer's Disease].[脑小血管病与阿尔茨海默病之间的关联]
Taehan Yongsang Uihakhoe Chi. 2022 May;83(3):486-507. doi: 10.3348/jksr.2022.0041. Epub 2022 May 25.
7
Application of Dynamic Enhanced Magnetic Resonance Imaging in the Diagnosis of Hematological Malignancies.动态增强磁共振成像在血液病诊断中的应用
J Healthc Eng. 2021 Dec 23;2021:4623850. doi: 10.1155/2021/4623850. eCollection 2021.
血管风险与β-淀粉样蛋白与皮质 Tau 呈协同相关。
Ann Neurol. 2019 Feb;85(2):272-279. doi: 10.1002/ana.25399. Epub 2019 Jan 7.
4
Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration.解开tau蛋白与铁的谜团:探索铁与tau蛋白在神经退行性变中的相互作用。
Front Mol Neurosci. 2018 Aug 17;11:276. doi: 10.3389/fnmol.2018.00276. eCollection 2018.
5
Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.血管风险和β-淀粉样蛋白负担与临床正常老年人认知能力下降的交互作用:哈佛衰老大脑研究的结果。
JAMA Neurol. 2018 Sep 1;75(9):1124-1131. doi: 10.1001/jamaneurol.2018.1123.
6
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.NIA-AA 研究框架:迈向阿尔茨海默病的生物学定义。
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.
7
Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.Tau 导致 P301L 转基因小鼠和人类阿尔茨海默病的血管异常和血管生成相关基因表达。
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1289-E1298. doi: 10.1073/pnas.1710329115. Epub 2018 Jan 22.
8
Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.脑脊髓液、MRI 和 Florbetaben-PET 检测在脑淀粉样血管病相关炎症中的应用。
J Alzheimers Dis. 2018;61(3):1107-1117. doi: 10.3233/JAD-170843.
9
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.比较多种 tau-PET 指标作为衰老和阿尔茨海默病的生物标志物。
Neuroimage. 2017 Aug 15;157:448-463. doi: 10.1016/j.neuroimage.2017.05.058. Epub 2017 Jun 3.
10
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.中年血管危险因素与估计的脑淀粉样蛋白沉积之间的关联。
JAMA. 2017 Apr 11;317(14):1443-1450. doi: 10.1001/jama.2017.3090.